10 Mar 2025 Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference Investors
07 Mar 2025 Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts Investors | Therapeutics
07 Mar 2025 Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update Diagnostics | Investors
29 Jan 2025 R&D Spotlight Series, Episode 8 Podcasts and Videos | R&D Spotlights Series | Therapeutics
16 Jan 2025 Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers Investors | Therapeutics
17 Dec 2024 Research & Development Spotlight Series – Episode 7 Investors | Podcasts and Videos | R&D Spotlights Series | Therapeutics